Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 237 | 201 | 63 | 0 | 0 |
| Cost of Goods | 45 | 45 | 45 | N/A | 0 |
| Gross Profit | 192 | 156 | 18 | N/A | 0 |
| Operating Expenses | 2,715 | 4,722 | 4,120 | 2,162 | 2,142 |
| Operating Income | -2,477 | -4,521 | -4,057 | -2,162 | -2,142 |
| Interest Expense | 63 | 68 | 72 | 79 | 51 |
| Other Income | -359 | 254 | 708 | -771 | 364 |
| Pre-tax Income | -2,899 | -4,335 | -3,421 | -3,012 | -1,829 |
| Net Income Continuous | -2,899 | -4,335 | -3,421 | -3,012 | -1,829 |
| Minority Interests | -159 | -800 | -363 | N/A | -96 |
| Net Income | $-2,739 | $-3,535 | $-3,058 | $-3,108 | $-1,733 |
| EPS Basic Total Ops | -0.58 | -1.17 | -1.11 | -5.44 | -0.05 |
| EPS Basic Continuous Ops | -0.61 | -1.17 | -1.11 | -5.44 | -0.05 |
| EPS Diluted Total Ops | -0.58 | -1.17 | -1.11 | -5.44 | -0.05 |
| EPS Diluted Continuous Ops | -0.61 | -1.17 | -1.11 | -5.44 | -0.05 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -1.17 | -1.11 | N/A | -1.00 |
| EBITDA(a) | $-2,124 | $-3,838 | $-3,662 | $-1,846 | $-1,892 |